Net shares · 365d
-209.3K
0 buy · 209.3K sell
Net value · 365d
-$1.1M
$0 in · $1.1M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
12
0 buy · 209.3K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$0
568 sh
Own +1%
-
GALT Sell·S
Chief Medical Officer · 10b5-1
$1.8K
568 sh · $3.10
Own -100%
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$699
568 sh · $1.23
Own New
-
GALT Grant·A
Chief Medical Officer · 10b5-1
$0
165.0K sh · 2 lots
Own New
-
GALT Sell·S
Chief Medical Officer · 10b5-1
$232.6K
60.0K sh · $3.88 avg · 3 lots
Own -100%
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$0
60.0K sh
Own New
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$0
60.0K sh
Own New
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$0
8.1K sh
Own +25%
-
GALT Sell·S
Chief Medical Officer · 10b5-1
$33.1K
8.1K sh · $4.07
Own -100%
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$10.0K
8.1K sh · $1.23
Own New
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$0
15.0K sh · 2 lots
Own +17%
-
GALT Sell·S
Chief Medical Officer · 10b5-1
$136.9K
19.4K sh · $7.04 avg · 3 lots
Own -100%
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$35.5K
15.0K sh · $2.37 avg · 2 lots
Own New
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$0
99.2K sh · 3 lots
Own +1073%
-
GALT Exercise·M
Chief Medical Officer · 10b5-1
$215.0K
99.2K sh · $2.17 avg · 3 lots
Own New
-
GALT Sell·S
Chief Medical Officer · 10b5-1
$662.5K
121.1K sh · $5.47 avg · 4 lots
Own -96%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 26, 2026 | GALT | Exercise M | 568 | $0 |
| May 26, 2026 | GALT | Sell S | 568 | $1.8K |
| May 26, 2026 | GALT | Exercise M | 568 | $699 |
| Jan 16, 2026 | GALT | Grant A | 165.0K2 lots | $0 |
| Jan 6, 2026 | GALT | Sell S | 60.0K3 lots | $232.6K |
| Jan 2, 2026 | GALT | Exercise M | 60.0K | $0 |
| Jan 1, 2026 | GALT | Exercise M | 60.0K | $0 |
| Dec 31, 2025 | GALT | Exercise M | 8.1K | $0 |
| Dec 31, 2025 | GALT | Sell S | 8.1K | $33.1K |
| Dec 31, 2025 | GALT | Exercise M | 8.1K | $10.0K |
| Dec 17, 2025 | GALT | Exercise M | 15.0K2 lots | $0 |
| Dec 17, 2025 | GALT | Sell S | 19.4K3 lots | $136.9K |
| Dec 17, 2025 | GALT | Exercise M | 15.0K2 lots | $35.5K |
| Nov 13, 2025 | GALT | Exercise M | 99.2K3 lots | $0 |
| Nov 13, 2025 | GALT | Exercise M | 99.2K3 lots | $215.0K |
| Nov 13, 2025 | GALT | Sell S | 121.1K4 lots | $662.5K |
Buy Sell Non-market (grant · exercise · gift)
About Jamil Khurram
This profile aggregates every SEC Form 4 insider transaction reported by Jamil Khurram across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.